Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Non-Current Assets: 2017-2019

Historic Other Non-Current Assets for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $143,000.

  • Astria Therapeutics' Other Non-Current Assets rose 26.55% to $143,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $143,000, marking a year-over-year increase of 26.55%. This contributed to the annual value of $254,000 for FY2018, which is 124.78% up from last year.
  • Per Astria Therapeutics' latest filing, its Other Non-Current Assets stood at $143,000 for Q3 2019, which was down 45.83% from $264,000 recorded in Q2 2019.
  • In the past 5 years, Astria Therapeutics' Other Non-Current Assets registered a high of $264,000 during Q2 2019, and its lowest value of $113,000 during Q1 2017.
  • Its 3-year average for Other Non-Current Assets is $142,273, with a median of $113,000 in 2019.
  • Data for Astria Therapeutics' Other Non-Current Assets shows a peak YoY spiked of 133.63% (in 2019) over the last 5 years.
  • Quarterly analysis of 3 years shows Astria Therapeutics' Other Non-Current Assets stood at $113,000 in 2017, then soared by 124.78% to $254,000 in 2018, then grew by 26.55% to $143,000 in 2019.
  • Its last three reported values are $143,000 in Q3 2019, $264,000 for Q2 2019, and $113,000 during Q1 2019.